Mizuho analysts rated Amsurg's stock as "buy" on June 26, according to Directors Talk.
Here are five points:
1. The Mizuho analysts set a price target of $95 on Amsurg's stock.
2. Mizuho predicts a potential upside of 20.4 percent from Amsurg's opening price of $78.88.
3. With a 50-day moving average of $78.60, Amsurg has a 200-day moving average of $77.36.
4. Amsurg stock's 52-week high is $87.42 and its 52-week low is $54.11.
5. In the past 90 trading days, Amsurg's share price increased 9.41 points.